Apollo Strategic Growth Capital II (NYSE:APGB) announced this morning that it has postponed its April 28 special meeting to 9 am ET on May 5.
Shareholders will be voting on a proposal to allow Apollo Strategic to extend its transaction deadline up to nine months from May 12, 2023 to February 12, 2024. Shareholders will have until May 3 to redeem their shares.
Apollo Strategic II also today announced that it entered into a non-redemption agreement with an unaffiliated third party. Under the non-redemption agreement, the investor agreed not to redeem an aggregate of 1,500,000 non-redeemed shares at the meeting, in exchange for which commitment the sponsor has agreed to transfer to the investor an aggregate of 300,000 Class B ordinary shares. The agreement is not expected to increase the likelihood that the extension proposal is approved by shareholders but will increase the amount of funds that remain in the trust account following the meeting.
The SPAC raised a total of $690 million in its February 2021 IPO, and originally had 24 months to complete a deal with the right to auto-extend up to three months.
It has not yet announced a combination agreement, but intends to combine with a leading company that exhibits positive top-line growth that is not reliant on leverage. Apollo II is led by CEO Sanjay Patel, Executive Chairman Scott Kleinman and CFO and Chief Acccounting Officer James Crossen.
Latest SPAC Liquidations: JAWS Hurricane JAWS Hurricane Acquisition Corporation (HCNE) to Liquidate on June 16 JAWS Hurricane Acquisition Corporation (Nasdaq: HCNE) today announced that its board of directors has determined not to proceed with a proposal to extend its corporate existence. As such, the Board has determined to cancel the special meeting of its stockholders,...
Jupiter Wellness Acquisition Corp. (NASDAQ:JWAC) announced this afternoon that it has completed its combination with Chinese carmaker Chijet. The deal was already approved by shareholders at a special meeting held on May 2, but at that time, the SPAC did not provide a timeline for the closing of the transaction. Although redemption numbers have still not...
The advent of summer is bringing nine lock-up expirations for de-SPAC’d companies and 10 on the sponsor side. The first change is to come for the sponsor of European Biotech Acquisition Corp., which closed its combination with Swiss pharma firm Oculis SA (NASDAQ:OCS) just three months ago. The sponsor is getting flexibility at a good...
Below is a daily summary of links to the latest SPAC news and rumors gathered across the web. Latest SPAC News: Lucid to raise $3B in a common stock offering from Saudi owners, Betsy Cohen says SPACs will make a comeback, and SatixFy makes another leadership change Lucid Raising $3 Billion With More Money From...
An article on Bloomberg yesterday announced what many in SPAC Land have been wondering after UBS acquired Credit Suisse – where was Niron Stabinsky, the Head of SPACs at Credit Suisse, going to land? The answer is Banco Santander SA, in what appears to be a massive lift of most (or nearly all) of Credit...